Semaglutide is a synthetic GLP-1 (glucagon-like peptide-1) receptor agonist that has garnered significant interest in metabolic research, particularly for its effects on glucose regulation and weight management. It is primarily studied for its potential to improve insulin sensitivity and decrease blood sugar levels in preclinical and clinical models. Semaglutide also plays a role in appetite regulation and is explored in studies focused on obesity and metabolic disorders.
Research into Semaglutide focuses on its ability to enhance glucose homeostasis, promote satiety, and regulate energy balance, making it a critical compound in the study of diabetes and metabolic diseases. Additionally, its effects on cardiovascular health are also under investigation, particularly concerning weight loss and blood pressure modulation.

Format: Lyophilized powder

Purity: ≥98%

Molecular formula: C187H291N45O59

Storage recommendations: Store at -20°C or lower. Keep lyophilized powder dry.

Intended research use: For studies on glucose metabolism, insulin sensitivity, obesity, and metabolic disorders.

For Research Use Only. Not for human consumption.